Interní Med. 2010; 12(7-8): 382-384

Orthostatic hypotension in Shy-Drager syndrome

MUDr.Tomáš Vařeka, MUDr.Magdaléna Dušejovská, MUDr.Jaroslav Macášek, prof.MUDr.Aleš Žák, DrSc., doc.MUDr.Miroslav Zeman, CSc.
IV. interní klinika, 1. lékařská fakulta Univerzity Karlovy v Praze a VFN, Praha

Chronic arterial hypotension refers to states when the blood pressure (BP) readings are below < 100/65 mm Hg in a long term. It is encountered

in organic damage to the central nervous system (CNS) or in diseases of the peripheral nervous system (PNS); drug-induced

hypotension is most commonly seen. Of major clinical significance is orthostatic hypotension that significantly limits the patients in their

activities of daily living. A case of a patient with organic damage to the CNS, Shy-Drager syndrome (SDS), with orthostatic hypotension as

a limiting factor, is described in the present case report. SDS is a rare and serious type of autonomic vegetative dysfunction, also referred

to as multiple system atrophy (MSA) or neurogenic orthostatic hypotension. It is a group of symptoms caused by the involvement of the

autonomic nervous system. The characteristic features are orthostatic hypotension, bradycardia, accommodation disorder, anhidrosis,

impaired tear and saliva secretion, gastrointestinal tract (GIT) dysmotility and voiding dysfunction. The underlying pathophysiology of

the disease involves neurodegenerative changes in the CNS in the brainstem region with resulting atrophy and pathological deposits

of alpha-synuclein in these CNS areas. The prognosis is serious; the disease decreases the quality of life and significantly reduces the

survival of patients.

Keywords: Shy-Drager syndrome, multiple system atrophy, orthostatic hypotension, catecholamines, autonomic dysfunction

Published: August 12, 2010  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Vařeka T, Dušejovská M, Macášek J, Žák A, Zeman M. Orthostatic hypotension in Shy-Drager syndrome. Interní Med. 2010;12(7-8):382-384.
Download citation

References

  1. Horký K. Chronická arteriální hypotenze. In: Aschermann M. Kardiologie, Praha Galén, 2004: 461-463.
  2. Shy M, Drager GA. A neurological syndrome associated with ortostatic hypotension: a clinical - pathologic study. Arch Neurol 1960; 2: 511-527. Go to original source... Go to PubMed...
  3. Gilman S, Wenning GK, Low PA, et al. Second consensus statement on the diagnosis of multiple system atrophy. Neurology 2008; 71: 670-676. Go to original source... Go to PubMed...
  4. Vanacore N. Epidemiological evidence on multiple system atrophy. J Neural Transm 2005; 112: 1605-1612. Go to original source... Go to PubMed...
  5. Ward C. An Ethical Dilemma Involving a Shy-Drage patient: A Case Study. Journal of Neuroscience Nursing, 2006; 38: 6. Go to original source... Go to PubMed...
  6. Quinn N, Wenning GK. Multiple system atrophy. Current Opinion in Neurology 1995; 8: 323-326. Go to original source... Go to PubMed...
  7. Benarroch EE. New finding on the neuropathology of multiple system atrophy. Autonomic Neuroscience: Basic and Clinical 2002; 96: 59-62. Go to original source... Go to PubMed...
  8. Gross G, Nagel-Hiemke M, Krause KH. Plasma Catecholamines During Activation of the Sympathetic Nervous System in a Patient with Shy-Drager Syndrome. J. Neurol. 1980; 224: 125-131. Go to original source... Go to PubMed...
  9. Gilman S, Low PA, Quinn N, et al. Consensus statement on the diagnosis of multiple system atrophy. J. Neurol. Sci. 1999; 163: 94-98. Go to original source... Go to PubMed...
  10. Wenning GK, Braune S. Multiple System Atrophy. CNS Drugs 2001; 15: 839-852. Go to original source... Go to PubMed...
  11. Zámečník L, et al. Renesance autokatetrizace u dysfunkcí dolních močových cest. Česká urologie, 1211-8729, 2000; 4(3): 34-34.
  12. Dušejovská M, Vařeka T, et al. Shyův-Dragerův syndrom - kazuistika. Čas Lék čes 2010; 149: 225-228.




Internal Medicine for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.